作者
Rui Zhang,Yixian Peng,Yuan Gao,Weiyin Kong,Baohua Lin,Mengmeng Deng,Zhiliao Chen,Yukun Liu,Qian Liu
摘要
BACKGROUND: Preeclampsia (PE) is a severe obstetric complication characterized by the new onset of hypertension and proteinuria after 20 weeks of gestation. However, bulk transcriptomic approaches cannot resolve cell type-specific alterations within the heterogeneous placenta. Single- cell RNA sequencing (scRNA-seq) enables gene expression profiling at individual-cell resolution, thereby revealing cellular heterogeneity and identifying cell populations and pathways potentially involved in disease processes. METHODS: This exploratory study integrated scRNA-seq data from one EOPE-FGR placental sample and one healthy control sample with bulk RNA-seq data. The Seurat and limma packages were used for single-cell and bulk transcriptomic analyses, respectively. Gene set enrichment analysis and differential expression analysis were performed to identify candidate pathways and genes. RT-qPCR was used to examine candidate gene expression, whereas the Cell Counting Kit-8 assay was used to assess the effect of FLT1 knockdown on cell viability under hypoxia/reoxygenation conditions. RESULTS: Exploratory scRNA-seq analysis identified ten major placental cell types. In the two analyzed samples, the EOPE-FGR sample showed a higher observed EVT proportion, whereas EVT cells displayed sample-specific glycolysis-, interferon-, and immune-related expression patterns. These single-cell observations were treated as exploratory. An exploratory intersection of bulk disease- versus-control differentially expressed genes with genes identified from the EVT high- versus low-glycolysis-score comparison prioritized 11 candidate genes: FLT1, PROCR, INHA, CST6, HTRA1, C12orf75, FSTL3, INHBA, CDA, EBI3, and PRG2. In supportive in vitro experiments, eight selected genes showed increased expression under hypoxia/reoxygenation conditions, and FLT1 knockdown was associated with an increased CCK-8 signal. The CCK-8 assay did not directly assess glycolytic activity. DISCUSSION: Bulk RNA-seq analysis identified glycolysis-related enrichment in EOPE-FGR placentas, whereas the single-cell datasets provided exploratory observations of EVT-associated expression patterns. Given the limited scRNA-seq sample size, these observations should be regarded as hypothesis-generating and require validation in larger independent cohorts. CONCLUSION: The integrated analyses prioritized candidate genes associated with bulk disease-related and within-sample EVT glycolysis-score-related expression patterns. These exploratory findings do not establish a causal relationship between FLT1, glycolytic activity, and immune alterations and require validation in larger cohorts and through direct metabolic assays.